Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
- PMID: 33901548
- PMCID: PMC8487768
- DOI: 10.1016/j.kint.2021.03.038
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
Expression of concern in
-
Expression of concern from the KI Editors: "Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria" [Kidney International, July 2021, Pages 146-154] and "APOL1-associated kidney disease in northern Nigerians with treated HIV infection" [Kidney International, July 2021, Pages 19-21].Kidney Int. 2022 Jan;101(1):188. doi: 10.1016/j.kint.2021.11.003. Epub 2021 Nov 20. Kidney Int. 2022. PMID: 34991808 No abstract available.
Abstract
HIV-positive adults are at risk for various kidney diseases, and apolipoprotein 1 (APOL1) high-risk genotypes increase this risk. This study aimed to determine the prevalence and ethnic distribution of APOL1 risk genotypes among a cohort of HIV-positive Nigerian adults and explore the relationship between APOL1 risk variant status with albuminuria and estimated glomerular filtration rate (eGFR). We conducted a cross-sectional study among 2 458 persons living with HIV who attended an HIV clinic in northern Nigeria and had received antiretroviral therapy for a minimum of six months. We collected two urine samples four-eight weeks apart to measure albumin excretion, and blood samples to measure eGFR and determine APOL1 genotype. The frequency of APOL1 high-risk genotype was 6.2%, which varied by ethnic group: Hausa/Fulani (2.1%), Igbo (49.1%), and Yoruba (14.5%). The prevalence of microalbuminuria (urine/albumin creatinine ratio 30- 300 mg/g) was 37%, and prevalence of macroalbuminuria (urine/albumin creatinine ratio over 300 mg/g) was 3%. The odds of microalbuminuria and macroalbuminuria were higher for participants with the APOL1 high-risk genotype compared to those carrying the low-risk genotype ([adjusted odds ratio 1.97, 95% confidence interval 1.37-2.82] and [3.96, 1.95-8.02] respectively). APOL1 high-risk genotype participants were at higher risk of having both an eGFR under 60 ml/min/1.73m2 and urine/albumin creatinine ratio over 300 mg/g (5.56, 1.57-19.69). Thus, we found a high proportion of HIV-positive, antiretroviral therapy-experienced, and largely virologically suppressed adults had microalbuminuria. Hence, although the high-risk APOL1 genotype was less prevalent than expected, it was strongly associated with some level of albuminuria.
Keywords: HIV; Nigeria; apolipoprotein 1; glomerular filtration rate; kidney disease; microalbuminuria.
Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
APOL1-associated kidney disease in northern Nigerians with treated HIV infection.Kidney Int. 2021 Jul;100(1):19-21. doi: 10.1016/j.kint.2021.04.023. Kidney Int. 2021. PMID: 34154709 Free PMC article.
References
-
- El-Sadr WM, Goosby E. Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV. AIDS. 2018;32:S1–S3. - PubMed
-
- Organization WH. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. World Health Organization; 2016. - PubMed
-
- Cohen SD, Kopp JB, Kimmel PL. Kidney Diseases Associated with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 2017;377(24):2363–2374. - PubMed
-
- Wyatt CM, Meliambro K, Klotman PE. Recent progress in HIV-associated nephropathy. Annual Review of Medicine. 2012;63:147–159. - PubMed
-
- Wools-Kaloustian KK, Gupta SK. Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell. Kidney International. 2008;74(7):845–847. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous